Global Coronary Stent Market

Coronary Stent Market Size, Share, Growth Analysis, By Product Type(Bare Metal Stents (BMS), Drug-Eluting Stents (DES)), By Biomaterial(Biomaterials, Polymeric Biomaterials) - Industry Forecast 2024-2031

Report ID: SQMIG35A2668 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 63 | Figures: 75

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Coronary Stent Market size was valued at USD 8.8 Billion in 2021 and is poised to grow from USD 9.09 Billion in 2022 to USD 11.79 Billion by 2030, at a CAGR of 3.3% during the forecast period (2023-2030).

The coronary stents market is highly competitive and characterized by the presence of several key players. These players compete based on factors such as product portfolio, technological advancements, pricing strategies, and market reach. The market is driven by continuous research and development efforts aimed at introducing innovative stent designs, improving drug-eluting capabilities, and enhancing biocompatibility. Market players focus on strategic collaborations, partnerships, and mergers and acquisitions to expand their market presence and gain a competitive edge. 'Abbott Laboratories (US)', 'Medtronic plc (Ireland)', 'Boston Scientific Corporation (US)', 'Terumo Corporation (Japan)', 'B. Braun Melsungen AG (Germany)', 'Johnson & Johnson (US)', 'Cook Medical Inc. (US)', 'C. R. Bard, Inc. (US)', 'Biosensors International Group, Ltd. (Singapore)', 'Meril Life Sciences Pvt. Ltd. (India)', 'MicroPort Scientific Corporation (China)', 'Biotronik SE & Co. KG (Germany)', 'Stentys SA (France)', 'Hexacath (France)', 'Translumina GmbH (Germany)', 'Elixir Medical Corporation (US)', 'Vascular Concepts (India)', 'Alvimedica (Turkey)', 'InspireMD Inc. (US)', 'Comed B.V. (Netherlands)'

The rising incidence of cardiovascular diseases, including coronary artery disease, is a major driver for the coronary stent market. Lifestyle changes, unhealthy diets, and sedentary lifestyles contribute to the growing burden of cardiovascular diseases globally.

Shift towards Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures, including percutaneous coronary intervention (PCI), which drives the demand for coronary stents. Minimally invasive procedures offer benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications compared to traditional open-heart surgeries.

The dominating region in the coronary stent market is North America, which holds a significant market share. With the presence of renowned casinos in Las Vegas and Atlantic City, North America has established itself as a gambling hub. The region boasts a thriving casino industry and is home to several major players in the gaming equipment market. The demand for cutting-edge gaming machines, electronic gaming tables, and other equipment is consistently high in this region, driving the growth of the market. North America's market share is estimated to be around 40%, making it a key player in the Coronary Stent market.

Related Reports

Sterile Tubing Welder Market
Buy Now GET FREE SAMPLE
Self-injection Devices Market
Buy Now GET FREE SAMPLE
Robotic Endoscopy Devices Market
Buy Now GET FREE SAMPLE
Durable Medical Equipment Rental Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Coronary Stent Market

Product ID: SQMIG35A2668

$5,300
BUY NOW